Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
International Bar Association
Best Lawyers in America
Chambers Global
Chambers USA
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Lawdragon
The Legal 500 Hall of Fame
The Legal 500 Latin America
The Legal 500 US
Deals & Cases
April 15, 2025
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $500 million registered fixed‑rate reset junior subordinated notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes will be listed on the Irish Stock Exchange. The transaction closed on April 1, 2025.
Deals & Cases
April 15, 2025
Cravath represented the underwriters in connection with the $4 billion registered senior notes offering of Dell International L.L.C. and EMC Corporation. Dell International L.L.C. and EMC Corporation are wholly‑owned subsidiaries of Dell Technologies, a leading integrated technology solutions provider in the IT industry. The transaction closed on April 1, 2025.
Deals & Cases
March 14, 2025
Cravath represented the underwriters in connection with the $2.75 billion registered senior notes and fixed‑to‑floating rate senior notes offering of State Street Corporation, a provider of a broad range of financial products and services to institutional investors worldwide. The transaction closed on February 28, 2025.
Deals & Cases
March 12, 2025
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
Deals & Cases
March 11, 2025
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of Kraft Heinz Foods Company, one of the largest food and beverage companies in the world at the time of the offering. Cravath also represented the underwriters in connection with Kraft Heinz Foods Company’s concurrent €600 million registered senior notes offering. The transactions closed on February 25, 2025.
Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
International Bar Association
Best Lawyers in America
Chambers Global
Chambers USA
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Lawdragon
The Legal 500 Hall of Fame
The Legal 500 Latin America
The Legal 500 US
Deals & Cases
April 15, 2025
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $500 million registered fixed‑rate reset junior subordinated notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes will be listed on the Irish Stock Exchange. The transaction closed on April 1, 2025.
Deals & Cases
April 15, 2025
Cravath represented the underwriters in connection with the $4 billion registered senior notes offering of Dell International L.L.C. and EMC Corporation. Dell International L.L.C. and EMC Corporation are wholly‑owned subsidiaries of Dell Technologies, a leading integrated technology solutions provider in the IT industry. The transaction closed on April 1, 2025.
Deals & Cases
March 14, 2025
Cravath represented the underwriters in connection with the $2.75 billion registered senior notes and fixed‑to‑floating rate senior notes offering of State Street Corporation, a provider of a broad range of financial products and services to institutional investors worldwide. The transaction closed on February 28, 2025.
Deals & Cases
March 12, 2025
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
Deals & Cases
March 11, 2025
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of Kraft Heinz Foods Company, one of the largest food and beverage companies in the world at the time of the offering. Cravath also represented the underwriters in connection with Kraft Heinz Foods Company’s concurrent €600 million registered senior notes offering. The transactions closed on February 25, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.